-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The production process of Bleomycinamide, N1-[3-[(4-aminobutyl)amino]propyl]-, hydrochloride, also known as Bleomycin, is a complex and multi-step process that involves several chemical reactions and purification steps.
The final product is a white to off-white crystalline powder that is used as an antibiotic and anti-tumor drug.
Step 1: Synthesis of N1-[3-[(4-aminobutyl)amino]propyl]-bleomycin
The first step in the production process of Bleomycin is the synthesis of N1-[3-[(4-aminobutyl)amino]propyl]-bleomycin, also known as BI-201255.
This compound is synthesized by reacting bleomycin-N-sulfate with 1,4-diaminobutane in the presence of a Lewis acid catalyst.
The reaction is carried out in a suitable solvent, such as a mixture of ethanol and water, and the product is purified by precipitation with ethanol and filtration.
Step 2: Hydrolysis of N1-[3-[(4-aminobutyl)amino]propyl]-bleomycin
The next step in the production process of Bleomycin is the hydrolysis of N1-[3-[(4-aminobutyl)amino]propyl]-bleomycin to produce the desired product, Bleomycinamide, N1-[3-[(4-aminobutyl)amino]propyl]-, hydrochloride.
This step is carried out by treating the N1-[3-[(4-aminobutyl)amino]propyl]-bleomycin with a suitable acid, such as hydrochloric acid, in a suitable solvent, such as a mixture of ethanol and water.
The product is then purified by filtration and dried to remove any remaining solvent.
Step 3: Purification of Bleomycinamide, N1-[3-[(4-aminobutyl)amino]propyl]-, hydrochloride
The final step in the production process of Bleomycinamide, N1-[3-[(4-aminobutyl)amino]propyl]-, hydrochloride is the purification of the product.
This is achieved by recrystallization of the product in a suitable solvent, such as ethanol, to remove any impurities and improve the purity of the final product.
The product is then dried and ground to a fine powder, which is then packaged and ready for use.
In conclusion, the production process of Bleomycinamide, N1-[3-[(4-aminobutyl)amino]propyl]-, hydrochloride, involves several chemical reactions and purification steps.
The final product is a white to off-white crystalline powder that is used as an antibiotic and anti-tumor drug.
The purity of the final product is critical for its efficacy and safety, and the production process must be designed and executed with care to ensure that the product meets the required specifications.
The production process of Bleomycinamide, N1-[3-[(4-aminobutyl)amino]propyl]-, hydrochloride, is a complex and multi-step process that requires specialized equipment and expertise to carry out successfully.
Only qualified and trained personnel should attempt to produce this product.